Skip to headlines
clockwire Search
LIVE
USMNT vs. Haiti live updates: Pochettino leads USA in farewell match in Concacaf Nations League SELLAS Life Sciences launches $150M public offering of its shares Ecuador ambassador praises King’s energy after inviting monarch to nation Can student exchange programs mend the relationship between the U.S. and China? This college football season's total opposite of a national title game LEEF Brands GAAP EPS of $0.00, revenue of $8.07M Wall Street ends in the red as tech continues its struggle Nvidia being probed by SEC after Huang's resignation: report ADC files appeal against Lifu’s judgment, seeks to stop INEC from altering party records Credit card delinquencies, charge-offs tick up amid solid spending: October Credit Pulse IIHF hit by apparent cyberattack days after excluding Russia from World Juniors MinRes does about face on unlimited exit bonuses after investor revolt ‘CHAOTIC AFTERMATH’: AKA told entourage Tembe threatened to jump before fatal fall, inquest hears Irish man charged over alleged sabotage of $60m US military aircraft at Shannon Airport McLaren explains reasons for Oscar Piastri deficit to Norris in 2026

Medical research & trials · US

Medical research & trials · US · 14 stories in 48h · Clear all filters

  1. Nasdaq.com Indices · United StatesNasdaq.comUS Edesa Biotech, Inc. Announces EU Orphan Designation for ParidiprubartOn November 17, 2026, Edesa Biotech, Inc. (the “Company”) announced that the European Commission has granted orphan designation…
  2. Nasdaq.com Indices · USNasdaq.comUS Adagene and City of Hope Open Clinical Trial to Test New Therapy for Patients with Hard-to-Treat Colorectal CancerAdagene Inc. and City of Hope have announced the launch of an investigator-initiated Phase 1 clinical trial to…
  3. Kernal Bio secures funding from IFLI for lymphoma treatment Markets · USInvesting.comGB Kernal Bio secures funding from IFLI for lymphoma treatment
  4. Valion Bio completes 200-liter Entolimod production run Markets · USInvesting.comGB Valion Bio completes 200-liter Entolimod production run
  5. Reuters Medical research & trials · USReutersGB J&J to buy eye disease biotech Ollin Biosciences for up to $3.3 billion 2 sources · Reuters, Investing.com
  6. Protagonist Therapeutics at Jefferies Global Healthcare Conference: partner-led growth Markets · USInvesting.comGB Protagonist Therapeutics at Jefferies Global Healthcare Conference: partner-led growth
  7. ‘Orwellian’: HIV scientist’s ordeal lays bare Trump officials’ interference in grant-making Donald Trump · United StatesThe GuardianGB ‘Orwellian’: HIV scientist’s ordeal lays bare Trump officials’ interference in grant-makingResearchers forced to scrap original studies as NIH rethinks grants not in ‘alignment’ with administration’s priorities Dr Jade…
  8. Common blood pressure drug helps more stroke survivors reach critical health target Medical research & trials · USFox NewsUS Common blood pressure drug helps more stroke survivors reach critical health targetThe REDUCE trial found spironolactone lowered blood pressure by nearly eight points in stroke survivors, but key questions…
  9. Investing.com Markets · USInvesting.comGB EyePoint at UBS biopharma conference: DME hopes offset wet AMD setback
  10. NKGen presents Alzheimer’s patient data at CTAD conference Markets · USInvesting.comGB NKGen presents Alzheimer’s patient data at CTAD conference
  11. Corvus Pharmaceuticals at Jefferies conference: oral ITK drug gains ground Markets · USInvesting.comGB Corvus Pharmaceuticals at Jefferies conference: oral ITK drug gains ground
  12. IN8bio reports survival data from glioblastoma trial Markets · USInvesting.comGB IN8bio reports survival data from glioblastoma trial
  13. United Therapeutics at UBS Global Biopharma Conference 2026: 2027 catalyst year Markets · USInvesting.comGB United Therapeutics at UBS Global Biopharma Conference 2026: 2027 catalyst year
  14. Ionis at UBS Global Biopharma Conference 2026: launch pace in focus Markets · USInvesting.comGB Ionis at UBS Global Biopharma Conference 2026: launch pace in focus

2 more stories in other languages (Portuguese 1, Spanish 1) ·